Kimia Biosciences touches roof on getting nod to manufacture, market ‘Obeticholic Acid’

10 Jun 2020 Evaluate

Kimia Biosciences is locked upper circuit limit of Rs. 24.75, up by 1.15 points or 4.87% from its previous closing of Rs. 23.60 on the BSE.

The scrip opened at Rs. 22.50 and has touched a high and low of Rs. 24.75 and Rs. 22.50 respectively. So far 2311 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 30.00 on 30-Oct-2019 and a 52 week low of Rs. 19.05 on 20-Feb-2020.

Last one week high and low of the scrip stood at Rs. 24.75 and Rs. 21.70 respectively. The current market cap of the company is Rs. 114.73 crore.

The promoters holding in the company stood at 70.93%, while Institutions and Non-Institutions held 0.44% and 28.62% respectively.

Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical Ingredient ‘Obeticholic Acid’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

 

Kimia Biosciences Share Price

43.00 -0.40 (-0.92%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.